Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shenzhen - Delayed Quote CNY

Dencare (Chongqing) Oral Care Co., Ltd. (001328.SZ)

Compare
41.81
-1.28
(-2.97%)
At close: April 3 at 3:04:15 PM GMT+8
Loading Chart for 001328.SZ
  • Previous Close 43.09
  • Open 39.89
  • Bid 41.75 x --
  • Ask 41.81 x --
  • Day's Range 40.03 - 43.99
  • 52 Week Range 19.70 - 43.99
  • Volume 2,554,900
  • Avg. Volume 1,856,368
  • Market Cap (intraday) 7.199B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 47.51
  • EPS (TTM) 0.88
  • Earnings Date --
  • Forward Dividend & Yield 0.65 (1.55%)
  • Ex-Dividend Date Jul 2, 2024
  • 1y Target Est 33.52

Dencare (Chongqing) Oral Care Co., Ltd. engages in the research, development, production, and sale oral care products in China. It provides oral cleaning and care products, such as toothpaste, toothbrush, and mouthwash; electric oral care products, including electric toothbrushes and irrigators; oral hygiene products, such as oral antibacterial paste and care solutions; and oral medical products that includes tooth desensitizers. The company offers its products under the Dengkang, Leng Suanling, Yiyan, Bellele, and Grender brands. Dencare (Chongqing) Oral Care Co., Ltd. was founded in 1939 and is based in Chongqing, China.

www.dencare.com.cn

1,093

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 001328.SZ

View More

Performance Overview: 001328.SZ

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

001328.SZ
31.64%
SSE Composite Index (000001.SS)
0.29%

1-Year Return

001328.SZ
88.99%
SSE Composite Index (000001.SS)
8.89%

3-Year Return

001328.SZ
1.98%
SSE Composite Index (000001.SS)
1.81%

5-Year Return

001328.SZ
1.98%
SSE Composite Index (000001.SS)
20.91%

Compare To: 001328.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 001328.SZ

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    7.20B

  • Enterprise Value

    5.84B

  • Trailing P/E

    47.36

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.05

  • Price/Book (mrq)

    5.10

  • Enterprise Value/Revenue

    4.12

  • Enterprise Value/EBITDA

    33.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.69%

  • Return on Assets (ttm)

    3.53%

  • Return on Equity (ttm)

    10.89%

  • Revenue (ttm)

    1.42B

  • Net Income Avi to Common (ttm)

    151.57M

  • Diluted EPS (ttm)

    0.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.36B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    64.4M

Research Analysis: 001328.SZ

View More

Company Insights: 001328.SZ

Research Reports: 001328.SZ

View More

People Also Watch